nodes	percent_of_prediction	percent_of_DWPC	metapath
Tasosartan—CYP3A4—Budesonide—ulcerative colitis	0.179	0.257	CbGbCtD
Tasosartan—CYP3A4—Methylprednisolone—ulcerative colitis	0.0801	0.115	CbGbCtD
Tasosartan—CYP3A4—Nicotine—ulcerative colitis	0.0781	0.112	CbGbCtD
Tasosartan—CYP3A4—Cholecalciferol—ulcerative colitis	0.07	0.1	CbGbCtD
Tasosartan—CYP3A4—Triamcinolone—ulcerative colitis	0.0607	0.0868	CbGbCtD
Tasosartan—CYP3A4—Betamethasone—ulcerative colitis	0.0521	0.0745	CbGbCtD
Tasosartan—CYP3A4—Prednisolone—ulcerative colitis	0.0514	0.0735	CbGbCtD
Tasosartan—CYP3A4—Hydrocortisone—ulcerative colitis	0.0487	0.0697	CbGbCtD
Tasosartan—CYP3A4—Prednisone—ulcerative colitis	0.0486	0.0694	CbGbCtD
Tasosartan—CYP3A4—Dexamethasone—ulcerative colitis	0.0303	0.0433	CbGbCtD
Tasosartan—AGTR2—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.0129	0.0445	CbGpPWpGaD
Tasosartan—AGTR2—Peptide GPCRs—CXCR1—ulcerative colitis	0.0126	0.0433	CbGpPWpGaD
Tasosartan—AGTR2—Peptide GPCRs—CXCR2—ulcerative colitis	0.00982	0.0339	CbGpPWpGaD
Tasosartan—AGTR2—Peptide GPCRs—CCR6—ulcerative colitis	0.00924	0.0319	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—MICA—ulcerative colitis	0.00921	0.0318	CbGpPWpGaD
Tasosartan—AGTR2—ACE Inhibitor Pathway—TGFB1—ulcerative colitis	0.0072	0.0248	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—CXCR1—ulcerative colitis	0.0059	0.0204	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—CCL20—ulcerative colitis	0.00518	0.0179	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—CXCR1—ulcerative colitis	0.00498	0.0172	CbGpPWpGaD
Tasosartan—AGTR2—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.00462	0.016	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.00462	0.0159	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—CCL20—ulcerative colitis	0.00437	0.0151	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.00434	0.015	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.0042	0.0145	CbGpPWpGaD
Tasosartan—AGTR1—Peptide GPCRs—CXCR1—ulcerative colitis	0.00409	0.0141	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.00396	0.0137	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—CXCR2—ulcerative colitis	0.0039	0.0135	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—CCR6—ulcerative colitis	0.00366	0.0126	CbGpPWpGaD
Tasosartan—AGTR1—Arf6 signaling events—ADRB2—ulcerative colitis	0.00365	0.0126	CbGpPWpGaD
Tasosartan—AGTR2—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.00362	0.0125	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.0035	0.0121	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.00348	0.012	CbGpPWpGaD
Tasosartan—AGTR2—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.0034	0.0117	CbGpPWpGaD
Tasosartan—AGTR1—Peptide GPCRs—CXCR2—ulcerative colitis	0.0032	0.011	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.0031	0.0107	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CXCR1—ulcerative colitis	0.00302	0.0104	CbGpPWpGaD
Tasosartan—AGTR1—Peptide GPCRs—CCR6—ulcerative colitis	0.00301	0.0104	CbGpPWpGaD
Tasosartan—AGTR2—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.00299	0.0103	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.00291	0.0101	CbGpPWpGaD
Tasosartan—AGTR1—Arf6 trafficking events—ADRB2—ulcerative colitis	0.00289	0.00996	CbGpPWpGaD
Tasosartan—Irbesartan—PTGS1—ulcerative colitis	0.00285	0.263	CrCbGaD
Tasosartan—Candesartan—PTGS1—ulcerative colitis	0.00285	0.263	CrCbGaD
Tasosartan—AGTR2—GPCR ligand binding—CCL20—ulcerative colitis	0.00265	0.00914	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.00257	0.00885	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL17A—ulcerative colitis	0.00248	0.00855	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CXCR2—ulcerative colitis	0.00236	0.00814	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.00235	0.00811	CbGpPWpGaD
Tasosartan—AGTR1—ACE Inhibitor Pathway—TGFB1—ulcerative colitis	0.00234	0.00809	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL12B—ulcerative colitis	0.0023	0.00795	CbGpPWpGaD
Tasosartan—AGTR2—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.00227	0.00783	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CCR6—ulcerative colitis	0.00222	0.00766	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—CTLA4—ulcerative colitis	0.00216	0.00747	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—ADCY5—ulcerative colitis	0.00208	0.00716	CbGpPWpGaD
Tasosartan—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.00196	0.00676	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—PTGER4—ulcerative colitis	0.00195	0.00674	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.00194	0.00671	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CXCR1—ulcerative colitis	0.00192	0.00664	CbGpPWpGaD
Tasosartan—Valsartan—ALB—ulcerative colitis	0.00192	0.177	CrCbGaD
Tasosartan—AGTR1—Allograft Rejection—HLA-DQA1—ulcerative colitis	0.00191	0.00658	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—GHRL—ulcerative colitis	0.00179	0.00617	CbGpPWpGaD
Tasosartan—AGTR1—Arf6 trafficking events—CDH1—ulcerative colitis	0.00174	0.00602	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—ABCB1—ulcerative colitis	0.00173	0.00598	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CXCR1—ulcerative colitis	0.0017	0.00588	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CCL20—ulcerative colitis	0.00169	0.00583	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL10—ulcerative colitis	0.00168	0.00581	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CXCR1—ulcerative colitis	0.00155	0.00534	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.00151	0.0052	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.00151	0.0052	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CCL20—ulcerative colitis	0.0015	0.00516	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—ADRB2—ulcerative colitis	0.00148	0.00511	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.00142	0.00489	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—RELA—ulcerative colitis	0.00141	0.00486	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—GNA12—ulcerative colitis	0.00141	0.00486	CbGpPWpGaD
Tasosartan—AGTR2—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.0014	0.00483	CbGpPWpGaD
Tasosartan—Candesartan—ABCB1—ulcerative colitis	0.00139	0.128	CrCbGaD
Tasosartan—AGTR2—Signaling by GPCR—CCL20—ulcerative colitis	0.00136	0.00469	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—HLA-DRB1—ulcerative colitis	0.00136	0.00468	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CXCR2—ulcerative colitis	0.00133	0.0046	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.00129	0.00445	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—GNA12—ulcerative colitis	0.00128	0.00441	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CCR6—ulcerative colitis	0.00125	0.00433	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CXCR2—ulcerative colitis	0.00121	0.00418	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NFKB1—ulcerative colitis	0.00119	0.0041	CbGpPWpGaD
Tasosartan—AGTR2—G alpha (i) signalling events—CXCL8—ulcerative colitis	0.00118	0.00408	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.00118	0.00407	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—GHRL—ulcerative colitis	0.00116	0.00399	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.00114	0.00394	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CCR6—ulcerative colitis	0.00114	0.00393	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.00113	0.00391	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SEL1L—ulcerative colitis	0.00111	0.00383	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.00111	0.00382	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PTGER4—ulcerative colitis	0.0011	0.00381	CbGpPWpGaD
Tasosartan—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.00107	0.0037	CbGpPWpGaD
Tasosartan—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.00107	0.00369	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.00103	0.00357	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—GHRL—ulcerative colitis	0.00101	0.00349	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.00101	0.00349	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PTGER4—ulcerative colitis	0.001	0.00346	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IFNG—ulcerative colitis	0.00099	0.00342	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CXCR1—ulcerative colitis	0.000983	0.00339	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000976	0.00337	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000949	0.00328	CbGpPWpGaD
Tasosartan—AGTR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000939	0.00324	CbGpPWpGaD
Tasosartan—Losartan—ALB—ulcerative colitis	0.000936	0.0864	CrCbGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—ulcerative colitis	0.000924	0.00319	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—CXCL8—ulcerative colitis	0.00092	0.00318	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—GHRL—ulcerative colitis	0.000918	0.00317	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CXCR1—ulcerative colitis	0.000914	0.00316	CbGpPWpGaD
Tasosartan—Losartan—ABCB1—ulcerative colitis	0.000893	0.0824	CrCbGaD
Tasosartan—AGTR2—Signaling by GPCR—CALM3—ulcerative colitis	0.000889	0.00307	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL1B—ulcerative colitis	0.000883	0.00305	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—IL2—ulcerative colitis	0.00088	0.00304	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCL20—ulcerative colitis	0.000863	0.00298	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000837	0.00289	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000836	0.00288	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCL20—ulcerative colitis	0.000803	0.00277	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CXCR2—ulcerative colitis	0.000769	0.00265	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000765	0.00264	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—ADRB2—ulcerative colitis	0.00076	0.00262	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—GNA12—ulcerative colitis	0.000755	0.0026	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000739	0.00255	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCR6—ulcerative colitis	0.000723	0.0025	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CXCR2—ulcerative colitis	0.000715	0.00247	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CXCL8—ulcerative colitis	0.000715	0.00247	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—ADCY5—ulcerative colitis	0.00071	0.00245	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—TGFB1—ulcerative colitis	0.000686	0.00237	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCR6—ulcerative colitis	0.000673	0.00232	CbGpPWpGaD
Tasosartan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000646	0.00223	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—ADCY5—ulcerative colitis	0.000645	0.00223	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—TNF—ulcerative colitis	0.000641	0.00221	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MAML2—ulcerative colitis	0.000638	0.0022	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—PTGER4—ulcerative colitis	0.000636	0.0022	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000633	0.00219	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000615	0.00212	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000614	0.00212	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PTGER4—ulcerative colitis	0.000592	0.00204	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—GHRL—ulcerative colitis	0.000583	0.00201	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000555	0.00192	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—GHRL—ulcerative colitis	0.000542	0.00187	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CALM3—ulcerative colitis	0.000525	0.00181	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—RIPK2—ulcerative colitis	0.000517	0.00179	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCR1—ulcerative colitis	0.000504	0.00174	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCL20—ulcerative colitis	0.000488	0.00168	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—ADRB2—ulcerative colitis	0.000482	0.00166	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GNA12—ulcerative colitis	0.000458	0.00158	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.000456	0.00157	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000453	0.00156	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000452	0.00156	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ADRB2—ulcerative colitis	0.000449	0.00155	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCL20—ulcerative colitis	0.000443	0.00153	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—JAK2—ulcerative colitis	0.000443	0.00153	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000435	0.0015	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000428	0.00148	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GNA12—ulcerative colitis	0.000416	0.00144	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCR6—ulcerative colitis	0.000409	0.00141	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000404	0.00139	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—JAK2—ulcerative colitis	0.000402	0.00139	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCR2—ulcerative colitis	0.000395	0.00136	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—IL2—ulcerative colitis	0.000386	0.00133	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ADCY5—ulcerative colitis	0.000381	0.00131	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCR6—ulcerative colitis	0.000371	0.00128	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CXCL8—ulcerative colitis	0.000367	0.00127	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SEL1L—ulcerative colitis	0.000362	0.00125	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PTGER4—ulcerative colitis	0.00036	0.00124	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL2—ulcerative colitis	0.000351	0.00121	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GHRL—ulcerative colitis	0.000329	0.00114	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PTGER4—ulcerative colitis	0.000327	0.00113	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000306	0.00106	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GHRL—ulcerative colitis	0.000299	0.00103	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCR1—ulcerative colitis	0.000298	0.00103	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CALM3—ulcerative colitis	0.00029	0.001	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000273	0.000941	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCL20—ulcerative colitis	0.000262	0.000903	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—ADRB2—ulcerative colitis	0.000248	0.000854	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GNA12—ulcerative colitis	0.000246	0.000849	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	0.00024	0.000829	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—JAK2—ulcerative colitis	0.000237	0.00082	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCR2—ulcerative colitis	0.000233	0.000805	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CXCL8—ulcerative colitis	0.000233	0.000804	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.000232	0.000801	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000231	0.000799	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—RELA—ulcerative colitis	0.00023	0.000794	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCR6—ulcerative colitis	0.000219	0.000756	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CXCL8—ulcerative colitis	0.000217	0.000748	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—ADCY5—ulcerative colitis	0.00021	0.000725	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MAML2—ulcerative colitis	0.000208	0.000717	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL2—ulcerative colitis	0.000207	0.000715	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL6—ulcerative colitis	0.000206	0.000711	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MMP9—ulcerative colitis	0.000196	0.000677	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NFKB1—ulcerative colitis	0.000194	0.000669	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTGER4—ulcerative colitis	0.000193	0.000666	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GHRL—ulcerative colitis	0.000177	0.00061	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—STAT3—ulcerative colitis	0.000174	0.000602	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CALM3—ulcerative colitis	0.000171	0.000591	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RIPK2—ulcerative colitis	0.000169	0.000582	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TGFB1—ulcerative colitis	0.000162	0.000558	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADRB2—ulcerative colitis	0.000146	0.000505	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—JAK2—ulcerative colitis	0.000144	0.000498	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TP53—ulcerative colitis	0.000133	0.000459	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000132	0.000454	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—JAK2—ulcerative colitis	0.000131	0.000452	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IL2—ulcerative colitis	0.000126	0.000434	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADCY5—ulcerative colitis	0.000124	0.000428	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL6—ulcerative colitis	0.000122	0.00042	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCL8—ulcerative colitis	0.00012	0.000413	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL2—ulcerative colitis	0.000114	0.000394	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CHP1—ulcerative colitis	9.85e-05	0.00034	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—DLD—ulcerative colitis	8.5e-05	0.000293	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—JAK2—ulcerative colitis	7.74e-05	0.000267	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RELA—ulcerative colitis	7.49e-05	0.000259	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCL8—ulcerative colitis	7.06e-05	0.000244	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL2—ulcerative colitis	6.75e-05	0.000233	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL6—ulcerative colitis	6.72e-05	0.000232	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MMP9—ulcerative colitis	6.39e-05	0.00022	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NFKB1—ulcerative colitis	6.32e-05	0.000218	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—STAT3—ulcerative colitis	5.68e-05	0.000196	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TGFB1—ulcerative colitis	5.26e-05	0.000182	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TP53—ulcerative colitis	4.33e-05	0.00015	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGS1—ulcerative colitis	4.11e-05	0.000142	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL6—ulcerative colitis	3.97e-05	0.000137	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CALM3—ulcerative colitis	3.7e-05	0.000128	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ABCB1—ulcerative colitis	2.88e-05	9.93e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ADCY5—ulcerative colitis	2.68e-05	9.26e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPARG—ulcerative colitis	2e-05	6.91e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALB—ulcerative colitis	1.8e-05	6.21e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.57e-05	5.44e-05	CbGpPWpGaD
